Quada, JR.; James C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Quada, JR.; James C..The latest application filed is for "combinations of a glp1r agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders".

Company Profile

0.12.6

Quada, JR.; James C. - High Point NC
Quada, Jr.; James C. - Hight Point NC
Quada, Jr.; James C. - San Antonio TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combinations of a GLP1R Agonist and Metformin and Use Thereof for the Treatment of Type 2 Diabetes and Other Disorders App 20150313908 - Mjalli; Adnan M.M. ; et al.	2015-11-05
Substituted azoanthracene derivatives and intermediates for preparation thereof Grant 9,175,003 - Mjalli , et al. November 3, 2	2015-11-03
Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof App 20150148539 - Mjalli; Adnan M.M. ; et al.	2015-05-28
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof Grant 8,987,295 - Mjalli , et al. March 24, 2	2015-03-24
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20130096150 - Mjalli; Adnan M.M. ; et al.	2013-04-18
Substituted Azole Derivatives, Compositions, and Methods of Use App 20110092553 - Mjalli; Adnan M.M. ; et al.	2011-04-21
Substituted Azole Derivatives as Therapeutic Agents App 20110077399 - Mjalli; Adnan M. M. ; et al.	2011-03-31
Solid Compositions Comprising An Oxadiazoanthracene Compound And Methods Of Making And Using The Same App 20110064806 - Polisetti; Dharma Rao ; et al.	2011-03-17
Compounds and methods for use thereof in the treatment of viral infections Grant 6,930,121 - Camden , et al. August 16, 2	2005-08-16
Compounds and methods for use thereof in the treatment of viral infections Grant 6,916,836 - Camden , et al. July 12, 2	2005-07-12
Benzimidazole compounds, and pharmaceutical compositions and unit dosages thereof Grant 6,900,235 - Agyin , et al. May 31, 2	2005-05-31
Compounds for use in the treatment of cancer or viral infections Grant 6,720,349 - Quada, Jr. , et al. April 13, 2	2004-04-13
Compounds and methods for use thereof in the treatment of cancer Grant 6,710,065 - Camden , et al. March 23, 2	2004-03-23
Compounds and methods for use thereof in the treatment of cancer or viral infections Grant 6,608,096 - Camden , et al. August 19, 2	2003-08-19
Compounds and methods for use thereof in the treatment of cancer or viral infections Grant 6,423,736 - Camden , et al. July 23, 2	2002-07-23
Compounds and methods for use thereof in the treatment of cancer or viral infections Grant 6,407,105 - Quada, Jr. , et al. June 18, 2	2002-06-18
Compounds and method for use thereof in the treatment of cancer or viral infections Grant 6,407,131 - Quada, Jr. , et al. June 18, 2	2002-06-18
Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof Grant 6,380,232 - Quada, Jr. , et al. April 30, 2	2002-04-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.